Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy

Published:2019 Issue:3 Volume:34 Page:215
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Liu Jierui¹²³^ORCID,Liu Yanqing¹²,Lin Yansong¹²³^ORCID,Liang Jun⁴^ORCID

Affiliation:

1. Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China.

2. Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.

3. Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.

4. Department of Oncology, Peking University International Hospital, Beijing, China.

Funder

National Natural Science Foundation of China

Chinese Academy of Medical Sciences

Asia Oceania Research Initiative Network

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.3803/EnM.2019.34.3.215

Reference95 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Recent incidences and differential trends of thyroid cancer in the USA

3. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013

4. Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

5. Molecular pathogenesis and mechanisms of thyroid cancer

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma;EJNMMI Research;2024-09-12

2. Detection of the BRAFV600E Mutation in Circulating Free Nucleic Acids as a Biomarker of Thyroid Cancer: A Review;Journal of Clinical Medicine;2024-09-12

3. Targeting the Akt signaling pathway: Exploiting curcumin's anticancer potential;Pathology - Research and Practice;2024-09

4. PET/RM nel carcinoma differenziato della tiroide: presente e futuro;L'Endocrinologo;2024-08

5. Ubiquitin-modifying enzymes in thyroid cancer：Mechanisms and functions;Heliyon;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3